Board of Directors

Ms. Lou Kennedy

President, Chief Executive Officer and Owner, Nephron Pharmaceuticals Corporation

Ms. Lou Kennedy is President, Chief Executive Officer and Owner of Nephron Pharmaceuticals Corporation. She joined Nephron Pharmaceuticals in 2001, and accepted the position of President and Chief Executive Officer in September 2007. Having held a variety of marketing and operational roles during her career; one notable achievement at Nephron was creating a national sales force, a rarity in the pharmaceutical industry. In the years following, this helped Nephron Pharmaceuticals grow by 300% and increased shipped product to one billion doses each of the last seven years.

Nephron recently built a state of the art manufacturing facility in West Columbia, South Carolina. Mrs. Kennedy was at the forefront of this expansion, which opened in June 2014. Lou is always seeking to enhance and grow her business. She started a 503B Outsourcing division of Nephron in 2016. Production for that division began in January 2017 and is rapidly increasing.

Along with her husband Bill, Mrs. Kennedy helped establish the Kennedy Pharmacy Innovation Center in conjunction with the USC School of Pharmacy. She serves on a variety of business and civic boards, including but not limited to, the South Carolina Chamber of Commerce, the National Bank of South Carolina Board, a division of Synovus, Columbia College Board of Trustees, South Carolina Manufacturers Alliance as well as the USC Athletic Department Board. Lou and Bill Kennedy were named Ambassadors of the Year by the Greater Columbia Chamber of Commerce in 2013. They also received the Lexington County Ambassador for Economic Development award in 2014. A graduate of the University of South Carolina’s College of Journalism with a Bachelor of Arts degree, Mrs. Kennedy never shies from the opportunity to cheer on the Gamecocks!

Board of Directors

BOARD MEETINGS

Dec 5, 2024
march 6, 2025
may 29, 2025
sep 4, 2025
dec 4, 2025
Dec 5, 2024
March 6, 2025
May 29, 2025
Sept 4, 2025
Dec 4, 2025

Sign up for our newsletter

Newsletter
crossmenu